Upregulation of Cysteine Protease Cathepsin X in the 6-Hydroxydopamine Model of Parkinson’s Disease
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by loss of midbrain dopaminergic neurons in the substantia nigra pars compacta (SNc). In vitro, a contribution to neuroinflammation and neurotoxicity has been shown for the lysosomal protease cathepsin X; however, its expression...
Main Authors: | Anja Pišlar, Larisa Tratnjek, Gordana Glavan, Marko Živin, Janko Kos |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-11-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnmol.2018.00412/full |
Similar Items
-
Neuroinflammation-Induced Upregulation of Glial Cathepsin X Expression and Activity in vivo
by: Anja Pišlar, et al.
Published: (2020-11-01) -
New Insights into the Role of Cysteine Cathepsins in Neuroinflammation
by: Anja Pišlar, et al.
Published: (2021-11-01) -
Lysosomal peptidases—intriguing roles in cancer progression and neurodegeneration
by: Janko Kos, et al.
Published: (2022-04-01) -
Cysteine Cathepsins as Therapeutic Targets in Immune Regulation and Immune Disorders
by: Emanuela Senjor, et al.
Published: (2023-02-01) -
Cathepsin X Activity Does Not Affect NK-Target Cell Synapse but Is Rather Distributed to Cytotoxic Granules
by: Tanja Jakoš, et al.
Published: (2021-12-01)